Prevention of Thromboembolic Events in Patients with COVID-19
| Autor: | Parameswaran Venugopal, Elizabeth Behrens, Surbhi Warrior, Joshua Thomas, Sefer Gezer, Shivi Jain |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
education.field_of_study business.industry Mortality rate Incidence (epidemiology) Population Hydroxychloroquine medicine.disease Thrombosis chemistry.chemical_compound Tocilizumab chemistry RC666-701 Internal medicine medicine Coagulopathy Diseases of the circulatory (Cardiovascular) system Dosing business education Letter to the Editor medicine.drug |
| Zdroj: | TH Open, Vol 05, Iss 03, Pp e415-e419 (2021) TH Open: Companion Journal to Thrombosis and Haemostasis |
| ISSN: | 2512-9465 |
| DOI: | 10.1055/a-1576-6201 |
| Popis: | Background: COVID-19 has developed into a global pandemic with respiratory compromise and systemic coagulopathy causing significant morbidity and mortality. Methods: A retrospective analysis was performed on all COVID-19 patients hospitalized between March and June 2020. Findings: Of 1265 COVID-19 positive hospitalized patients identified, 138 (10.9%) had a thromboembolism. Mortality rate in COVID-19 patients with thrombosis was 31.9%, significantly higher than COVID-19 patients who did not have thrombosis 10% (p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|